date:Sep 18, 2012
ed four publihed and one ongoing randomized controlled trials that met selection criteria and included them in their review.
The outcomes considered in the trials included neonatal death, infant death, bronchopulmonary dysplasia, retinopathy of prematurity, intraventricular hemorrhage, necrotizing enterocolitis, and sepsis.
From three trials, the researchers found inositol supplementation reduced risk of neonatal death by 47 percent, infant deaths by 45 percent, retinopathy of prematurity, st